Overview
- 207 inspections across 166 sites are on record.
- 511 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-14.
At a glance
Inspections
207
Sites
166
Observations
511
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Fosun Pharma (Xuzhou) Co., Ltd | 14 May 2026 | Human Drugs | |
| CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 9 Apr 2026 | Human Drugs | On file |
| Yabao Pharmaceutical Co., Ltd. Beijing | 6 Mar 2026 | Human Drugs | On file |
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) | 15 Dec 2025 | Human Drugs | On file |
| Sichuan Huiyu Pharmaceutical Co., Ltd. | 6 Nov 2025 | Human Drugs | On file |
Sites inspected
Fosun Pharma (Xuzhou) Co., LtdXuzhou, China1 insp.
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Shijiazhuang, China1 insp.
Yabao Pharmaceutical Co., Ltd. BeijingTongzhou, China1 insp.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)Nanjing, China1 insp.
Sichuan Huiyu Pharmaceutical Co., Ltd.Nei Jiang, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Debra A Taylor14 shared
Samantha J Bradley8 shared
Wayne S Fortenberry6 shared
Zada L Giles6 shared
Grant D Jones6 shared
Amanda K Willey6 shared
Jason D Tenney5 shared
Katherine Szestypalow4 shared
Martrice A Packer3 shared
Tsz Kwan K Ngan3 shared
Full investigator report
Get the verbatim findings behind Marvin D Jones' 511 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site